27 results on '"Attard P"'
Search Results
2. DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer
3. Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide
4. Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids
5. Dysregulation of cholesterol metabolism in cancer progression
6. Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth
7. DNMT1-mediated epigenetic silencing of TRAF6 promotes prostate cancer tumorigenesis and metastasis by enhancing EZH2 stability
8. Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells
9. Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer
10. Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing
11. Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer
12. Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy
13. Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence
14. Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer
15. Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy
16. A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer
17. Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12
18. O-GlcNAcylation modulates Bmi-1 protein stability and potential oncogenic function in prostate cancer
19. Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis
20. Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer
21. Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth
22. HDAC inhibition impedes epithelial–mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer
23. The biology of circulating tumor cells
24. Arrestin2 modulates androgen receptor activation
25. DNA damage response and prostate cancer: defects, regulation and therapeutic implications
26. TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
27. Intratumoral heterogeneity of ADAM23 promotes tumor growth and metastasis through LGI4 and nitric oxide signals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.